Cedars-Sinai Appoints Director of Newly Established Translational Research Institute

Cedars-Sinai has appointed Ze’ev Ronai, PhD, as director of a newly established Translational Research Institute, professor in the Department of Biomedical Sciences and the Jim and Eleanor Randall Department of Surgery as well as the scientific director of the Surgical Melanoma Research Program in the Randall Department of Surgery.

Lauren Hackett, M.P.A., to Lead Operations at NCI-Designated Albert Einstein Cancer Center

Today, Albert Einstein Cancer Center (AECC), Albert Einstein College of Medicine, and Montefiore Health System announced that Lauren Hackett, M.P.A., has been appointed the deputy director of administration of AECC and associate vice president of cancer medicine at Montefiore Medicine. Ms. Hackett, who is currently the chief operating officer at the Allen Institute, will assume her new roles in August 2021.

The Tisch Cancer Institute Earns Second Consecutive Designation from National Cancer Institute

The Tisch Cancer Institute at Mount Sinai (TCI) has been awarded $13 million as part of the renewal of its National Cancer Institute Cancer Center Designation, a prestigious distinction that is based on scientific excellence, robust clinical research, and beneficial community impact. The National Cancer Institute rated TCI’s application as “outstanding.”